Is Antiplatelet Therapy Sufficient for DRT and Stroke Prevention After LAAC?

Disclosure(s):

Jacqueline Saw, MD: Abbott Cardiovascular Systems: Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Consultant/Advisory Board (Ongoing), Educational Grant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Ongoing), Educational Grant (Ongoing), Grant/Research Support (Ongoing)